32 results about "Thionazin" patented technology

The present invention relates to novel heterocyclic pro-fragrances, preferably oxazolidines, tertahydro-1,3-oxazines, thiazolidines, or tetrahydro-1,3-thiazines, more preferably oxazolidines, or tertahydro-1,3-oxazines, most preferably oxazolidines, which are capable of sustained release of fragrance raw material ketones and aldehydes and to fragrance delivery systems which comprise said pro-fragrances.

The invention relates to a phenothiazine co-sensitizer and its preparation method and application. The co-sensitizer uses phenothiazine as a raw material and is prepared by suzuki coupling, borate esterification, bromination, hydrolysis and other reactions. The target co-sensitizer compound was obtained. The co-sensitizer of the present invention has a 2D-π-2A structure, with double-long carbon chain modified phenothiazine as the electron donor end, and a double carboxyl group as the electron acceptor end and simultaneously as an anchoring group. This structure has two A carboxyl group is used as an anchor group, so it will have good adsorption stability. After co-sensitization with porphyrin dye YD2‑O‑C8, it has a better effect, and the conversion efficiency of solar cell devices can be increased to 8.78%. The increase is about 18%. This structure is beneficial to fill the adsorption gap between the main porphyrin dyes, so that it can also play a role in reducing charge recombination on the basis of increasing the short-circuit current.

The invention discloses molecularly imprinted polymer with phenothiazine drug specificity, a chemiluminiscence kit and a detection method. The molecularly imprinted polymer is prepared by taking 2-trifluoromethyl phenothiazine as a molecular template, methacrylic acid as functional monomer, azodiisobutyronitrile as an initiator, and ethylene dimethacrylate as a crosslinking agent. The chemiluminiscence kit is prepared by taking a molecularly imprinted compound as a core reagent, imidazole as a catalyst, and bis (2, 4, 6-trichlorophenyl) oxalic ester and hydrogen peroxide as chemiluminescence reagents, and meanwhile the detection method adopting the kit is further provided. The molecularly imprinted polymer can capture various phenothiazine drugs, and the chemiluminiscence kit can accurately, rapidly and efficiently detect various phenothiazine drugs.

The invention discloses a method for synthesizing 1,2-benzothiazine compounds. Sulfoximine is used as a guiding group, transition metal palladium is used as a catalyst, and in the presence of fluoride, a sulfoximine compound is used. A series of 1,2-benzothiazine compounds were synthesized by cyclization reaction activated by C-H or N-H bonds with aryl alkyne precursors as reaction substrates. The present invention has simple and easy-to-obtain raw materials, mild reaction conditions, realizes the construction of C-C and C-N bonds, shortens the synthesis route, and conforms to the concept of green environmental protection.

Novel 2,8-diaminophenothiazine compounds of the following formula:and a method for preparing the same, are presented. The 2,8-diaminophenothiazine compounds are useful in the field of treating liquid or gaseous fluids, especially influents and industrial or domestic effluents.

The invention belongs to the field of organic synthetic medicine, and specifically relates to a small-molecule oxathiazine derivative, whose general formula is as follows: the small-molecule oxthiazine derivative can be used as a positive allosteric regulator of AMPA receptors, which proves that The compound can positively regulate the AMPA receptor, and can make the conformation of the agonist (such as endogenous neurotransmitter glutamate) more stable after binding to the receptor, thereby reducing the inactivation rate of the receptor and inhibiting the desensitization of the receptor. Enhance the function of AMPA receptors.

The invention belongs to the field of organic synthetic medicine, and specifically relates to an oxathiazine compound, the general formula of which is as follows: the oxthiazine compound can be used as a positive allosteric regulator of AMPA receptors, and it has been confirmed that the compound can positively regulate AMPA receptors can make the conformation of agonists (such as endogenous neurotransmitter glutamate) more stable after binding to receptors, thereby reducing the rate of receptor inactivation and inhibiting receptor desensitization, so that the function of AMPA receptors Can be strengthened, its drug-like property is remarkable, has broad market prospect.

The invention relates to N-substituted benzenesulfonyl phenothiazine compounds as well as a preparation method and application thereof, and particularly relates to N-substituted benzenesulfonyl phenothiazine compounds having a structure shown in a formula I described in the specification as well as a preparation method thereof, pharmaceutical compositions taking the N-substituted benzenesulfonyl phenothiazine compounds with a structure as shown in the formula I as active ingredients and use of the pharmaceutical compositions for preventing or treating diseases associated with an arginine vasopressin V1a receptor, an arginine vasopressin V1b receptor, an arginine vasopressin V2 receptor, a sympathetic nervous system or a rennin-angiotensin-aldosterone system.